WallStreetZenWallStreetZen

NASDAQ: TARS
Tarsus Pharmaceuticals Inc Stock Ownership - Who owns Tarsus Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Tarsus Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Seshadri NeervannanChief Operating Officer2026-03-202,989$66.75
$199.52kSell
Aziz MottiwalaChief Commercial Officer2026-03-194,440$67.00
$297.48kSell
Seshadri NeervannanChief Operating Officer2026-03-194,589$67.00
$307.46kSell
Dianne C. WhitfieldChief Human Resources Officer2026-03-194,174$67.00
$279.66kSell
Bobak R. AzamianPresidentCEO and Board Chair2026-03-1911,964$67.00
$801.59kSell
Jeffrey S. FarrowChief Financial Officer and Chief Strategy Officer2026-03-192,186$67.00
$146.46kSell
Bryan WahlGeneral Counsel2026-03-194,231$67.00
$283.48kSell
Elizabeth Yeu LinChief Medical Officer2026-03-19390$67.00
$26.13kSell
Dianne C. WhitfieldChief Human Resources Officer2026-03-184,071$68.71
$279.72kSell
Jeffrey S. FarrowChief Financial Officer and Chief Strategy Officer2026-03-182,133$68.71
$146.56kSell

1 of 5

TARS insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when TARS insiders and whales buy or sell their stock.

TARS Shareholders

What type of owners hold Tarsus Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Vivo Capital IX LLC13.28%5,714,036$353.98MInsider
Deep Track Capital LP8.37%3,600,000$223.02MInstitution
Blackrock Inc8.26%3,552,612$220.08MInstitution
Rtw Investments LP7.78%3,346,025$207.29MInstitution
Paradigm Biocapital Advisors LP5.96%2,562,154$158.73MInstitution
Janus Henderson Group PLC5.21%2,240,963$138.83MInstitution
Rtw Investments LP4.68%2,013,601$124.74MInsider
Horowitz Limited Partnership VIII4.62%1,987,105$123.10MInsider
Jason E. Tester4.53%1,949,331$120.76MInsider
Morgan Stanley4.52%1,944,272$120.45MInstitution

1 of 3

TARS vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
TARS73.42%26.58%Net SellingNet Selling
IDYA92.57%7.43%Net Buying
IRON62.62%37.38%Net SellingNet Selling
DFTX63.44%36.56%Net SellingNet Selling
ELVN50.94%49.06%Net SellingNet Selling
View Top Biotech Stocks

Tarsus Pharmaceuticals Stock Ownership FAQ

Who owns Tarsus Pharmaceuticals?

Tarsus Pharmaceuticals (NASDAQ: TARS) is owned by 104.92% institutional shareholders, 37.99% Tarsus Pharmaceuticals insiders, and 0.00% retail investors. Vivo Capital IX LLC is the largest individual Tarsus Pharmaceuticals shareholder, owning 5.71M shares representing 13.28% of the company. Vivo Capital IX LLC's Tarsus Pharmaceuticals shares are currently valued at $353.41M.

If you're new to stock investing, here's how to buy Tarsus Pharmaceuticals stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.